Clin2
NCT07661446Possibly a fitNot yet recruiting

Cannabis for opioid withdrawal help

Opioid Use DisordersCannabis Use

Part of Mental health clinical trials.

This study is testing whether cannabis (marijuana) can help people who are dependent on opioids manage withdrawal symptoms and reduce opioid use.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must have moderate to severe opioid use disorder (a diagnosis by a healthcare provider).
  • You need to currently use opioids on a regular basis.
  • You must have withdrawal symptoms when you stop using opioids.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07668635Not yet recruiting· Phase 1
Testing cannabis for reducing opioid withdrawal and use

This study tests whether cannabis can help ease opioid withdrawal and reduce opioid use. Participants will stay at the hospital for about 6 weeks to receive the study treatment and be closely monitored.

Lexington, Kentucky
NCT05729932Recruiting· Phase 1
Cannabis and opioid use disorder study

This Phase 1 trial studies cannabis in people with opioid use disorder. The goal is to better understand how it may affect opioid use disorder, while monitoring safety.

Lexington, Kentucky
NCT05985850Recruiting· Phase 2
Can cannabis help with opioid addiction treatment?

This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.

Vancouver, British Columbia
NCT07148206Not yet recruiting· Phase 3
Cannabis-like medicines for withdrawal symptoms when starting buprenorphine

This trial tests whether two cannabis-like medicines, dronabinol and Epidiolex, can help reduce withdrawal symptoms and other discomforts people may feel when they first start taking buprenorphine for opioid use disorder. If you've recently started buprenorphine and still have symptoms, this study might offer extra relief.

The Bronx, New York
NCT06544291Recruiting· Phase 2
THC and CBD for pain and opioid use disorder

This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.

New Haven, Connecticut
NCT06940674Recruiting· Phase 3
CBD plus opioid treatment for recovery

This study tests whether adding cannabidiol (CBD) to your usual methadone or buprenorphine treatment helps you recover from opioid use disorder. If you're already in stable treatment with those medications, the trial aims to see if CBD can improve your outcomes.

New York, New York

Hear when a new Cannabis Use trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.